Sodium Bicarbonate Excipient | Pharmaceutical Excipients for Piperacillin Sodium

01

SPI Pharma

U.S.A

World Vaccine Conference

Not Confirmed

SPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Grade : Oral

Brand Name : Effer-Soda

Application : API Stability Enhancers

Excipient Details : Effer-Soda is a surface modified sodium bicarbonate powder that eliminates formulation instability, expensive packaging & premature effervescence.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Sodium Bicarbonate Excipient

Dosage Form : Tablet

Grade : Oral

SPI Pharma has been solving formulation challenges using superior functional materials.

Ingredient(s) : Sodium Bicarbonate Excipient

Dosage Form : Tablet

Category : API Stability Enhancers

Brand : EFFER-SODA

Applications : Effer-Soda is a surface modified sodium bicarbonate powder that eliminates formulation instability, expensive packaging & premature effervescence.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

02

Actylis

HYDROCHLORIC ACID NF

German Wound Congress

Not Confirmed

03

Roquette

DEXTROSE MONOHYDRATE F

German Wound Congress

Not Confirmed

04

Roquette

LYCADEX® BIOPHARMA

German Wound Congress

Not Confirmed

05

Roquette

ROQUETTE DEXTROSE MONOHYDRATE G

German Wound Congress

Not Confirmed

06

Roquette

LYCADEX® PF

German Wound Congress

Not Confirmed

Looking for Piperacillin Sodium? Find Piperacillin Sodium based excipient solutions to address drug delivery challenges on PharmaCompass.

Piperacillin Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers

14 USDMF

13 CEP/COS

13 JDMF

3 EU WC

12 KDMF

13 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

165 FDF Dossiers

67 FDA Orange Book

53 Europe

13 South Africa

32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML

INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 Actylis

4 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Fillers, Diluents & Binders

1 API Stability Enhancers

DIGITAL CONTENT

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

51 Regulatory FDF Prices

5 Annual Reports

MARKET PLACE

6 APIs

5 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

2 USP

7 Others

Filters

01

02

03

04

05

06

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons